Edit
Tisbury Pharmaceutical
http://www.tisburypharmaceuticals.com/Last activity: 19.02.2021
Probably Closed - Reference to Mercusuar
Tisbury Pharmaceutical Inc (Tisbury Pharmaceuticals BV). is a pharmaceutical company developing a first-in-class drug to treat glaucoma. Its primary development target is patients with open angle glaucoma and ocular hypertension patients.
Location: United States, Massachusetts, Beverly
Employees: 11-50
Total raised: $32M
Founded date: 2017
Investors 1
| Date | Name | Website |
| 19.02.2021 | HealthCap | healthcap.... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 16.06.2017 | Series A | $32M | - |
Mentions in press and media 2
| Date | Title | Description |
| 16.06.2017 | Tisbury Pharmaceuticals Raises $32M in Series A Financing | Tisbury Pharmaceuticals, Inc., a Boston, MA-based pharmaceutical company focused on the discovery and development of therapeutics for the treatment of glaucoma, secured $32m Series A funding. The round was led by OrbiMed Israel, Clarus, and... |
| - | Tisbury Pharmaceuticals Launches with a USD 32 Million Series A Financing to Develop First-in-class Therapeutics for Glaucoma | Boston, Massachusetts (PRWEB) June 14, 2017 Tisbury Pharmaceuticals, Inc., a pharmaceutical company focused on the discovery and development of first-in-class therapeutics for the treatment of glaucoma has secured $32 million Series A fina... |